NCT03574311 - Preoperative Intravenous Ferric Carboxymaltose and Placebo in the Treatment of Patients Undergoing Cardiac Surgery | Biotech Hunter

Enrollment

210

Participants

Timeline

Start Date

October 2, 2018

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2023

Conditions

Coronary Artery DiseasePostoperative ComplicationsAortic Valve StenosisMitral Valve DiseaseAortic Aneurysm, Thoracic

Interventions

DRUG

Ferric carboxymaltose

A single dose of drug or placebo is administered preoperatively to participants

OTHER

Physiological saline

Single infusion 100 ml physiological saline infusion preoperatively

Trial Locations (1)

RECRUITING

Turku University Hospital, Turku